Modulation of UL24 interactions with protein targets and uses thereof for inhibition of herpesvirus infection

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8771698
APP PUB NO 20130108649A1
SERIAL NO

13661212

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods and uses for the treatment of herpesvirus infection based on the inhibition of the interaction between herpesvirus UL24 and non-muscle myosin type IIa (NM2a) are described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE490 DE LA COURONNE QUÉBEC G1K 9A9

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bertrand, Luc Laval, CA 4 151
Pearson, Angela Mont-Royal, CA 1 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 8, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00